Correspondence 0000950103-24-011991 from ADC Therapeutics SA (ADCT)
ADC Therapeutics SA
Date: Aug. 9, 2024 · CIK: 0001771910 · Accession: 0000950103-24-011991
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281288
Letter
Re: ADC Therapeutics SA
August 9, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
Registration No. 333-281288
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-281288) (the “Registration Statement”) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m., Eastern time, on August 13, 2024, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.
Thank you for your assistance in this matter.
Sincerely,
ADC Therapeutics SA
Show Raw Text
CORRESP
1
filename1.htm
August 9, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
ADC Therapeutics SA
Registration Statement on Form S-3
Registration No. 333-281288
In accordance with Rule 461 under the Securities Act of 1933, as amended,
we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-281288) (the “Registration
Statement”) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m.,
Eastern time, on August 13, 2024, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.
Thank you for your assistance in this matter.
Sincerely,
ADC Therapeutics SA
By:
/s/ Peter J. Graham
Name: Peter J. Graham
Title: Chief Legal Officer